Detalhe da pesquisa
1.
Early dynamic imaging in 68Ga- PSMA-11 PET/CT allows discrimination of urinary bladder activity and prostate cancer lesions.
Eur J Nucl Med Mol Imaging;
44(5): 765-775, 2017 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27900519
2.
Direct comparison of (68)Ga-DOTA-TOC and (18)F-FDG PET/CT in the follow-up of patients with neuroendocrine tumour treated with the first full peptide receptor radionuclide therapy cycle.
Eur J Nucl Med Mol Imaging;
43(9): 1585-92, 2016 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26922350
3.
Current knowledge on the sensitivity of the (68)Ga-somatostatin receptor positron emission tomography and the SUVmax reference range for management of pancreatic neuroendocrine tumours.
Eur J Nucl Med Mol Imaging;
43(11): 2072-83, 2016 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27174220
4.
Correlation of dopaminergic terminal dysfunction and microstructural abnormalities of the basal ganglia and the olfactory tract in Parkinson's disease.
Brain;
136(Pt 10): 3028-37, 2013 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24014521
5.
Somatostatin receptor PET in neuroendocrine tumours: 68Ga-DOTA0,Tyr3-octreotide versus 68Ga-DOTA0-lanreotide.
Eur J Nucl Med Mol Imaging;
40(3): 364-72, 2013 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23151915
6.
Preliminary Clinical Experience with Cholecystokinin-2 Receptor PET/CT Using the 68Ga-Labeled Minigastrin Analog DOTA-MGS5 in Patients with Medullary Thyroid Cancer.
J Nucl Med;
64(6): 859-862, 2023 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36657979
7.
Diagnostic Reference Levels for nuclear medicine imaging in Austria: A nationwide survey of used dose levels for adult patients.
Z Med Phys;
32(3): 283-295, 2022 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35067426
8.
A novel computer-assisted image analysis of [123I]ß-CIT SPECT images improves the diagnostic accuracy of parkinsonian disorders.
Eur J Nucl Med Mol Imaging;
38(4): 702-10, 2011 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-21174092
9.
Functional imaging in phaeochromocytoma and neuroblastoma with 68Ga-DOTA-Tyr 3-octreotide positron emission tomography and 123I-metaiodobenzylguanidine.
Eur J Nucl Med Mol Imaging;
38(5): 865-73, 2011 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-21279352
10.
Radiation exposure after 177Lu-DOTATATE and 177Lu-PSMA-617 therapy.
Ann Nucl Med;
32(7): 499-502, 2018 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29797003
11.
Functional imaging in phaeochromocytoma and neuroblastoma with 68Ga-DOTA-Tyr3-octreotide positron emission tomography and 123I-metaiodobenzylguanidine: a clarification.
Eur J Nucl Med Mol Imaging;
39(3): 543, 2012 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-22237841